Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data

Ashish Sharma; M. Hafeez Faridi; Nilesh Kumar; Nikulaa Parachuri; Rohini Sharma; Baruch D. Kuppermann; Francesco Bandello; Anat Loewenstein; Carl D. Regillo

doi:10.1038/s41433-019-0745-z

Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data

Ashish Sharma^*, M. Hafeez Faridi, Nilesh Kumar, Nikulaa Parachuri, Rohini Sharma, Baruch D. Kuppermann, Francesco Bandello, Anat Loewenstein, Carl D. Regillo

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1008-1009
Number of pages	2
Journal	Eye
Volume	34
Issue number	6
DOIs	https://doi.org/10.1038/s41433-019-0745-z
State	Published - 1 Jun 2020

Access to Document

10.1038/s41433-019-0745-z

Cite this

@article{380b52b135a94f14883490b1999d54cc,

title = "Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data",

author = "Ashish Sharma and {Hafeez Faridi}, M. and Nilesh Kumar and Nikulaa Parachuri and Rohini Sharma and Kuppermann, {Baruch D.} and Francesco Bandello and Anat Loewenstein and Regillo, {Carl D.}",

year = "2020",

month = jun,

day = "1",

doi = "10.1038/s41433-019-0745-z",

language = "אנגלית",

volume = "34",

pages = "1008--1009",

journal = "Eye",

issn = "0950-222X",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar

T2 - real-world data

AU - Sharma, Ashish

AU - Hafeez Faridi, M.

AU - Kumar, Nilesh

AU - Parachuri, Nikulaa

AU - Sharma, Rohini

AU - Kuppermann, Baruch D.

AU - Bandello, Francesco

AU - Loewenstein, Anat

AU - Regillo, Carl D.

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85076525529&partnerID=8YFLogxK

U2 - 10.1038/s41433-019-0745-z

DO - 10.1038/s41433-019-0745-z

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 31844168

AN - SCOPUS:85076525529

SN - 0950-222X

VL - 34

SP - 1008

EP - 1009

JO - Eye

JF - Eye

IS - 6

ER -

Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data

Access to Document

Other files and links

Cite this